[ Price : $8.95]
Amylyx Pharmaceuticals discontinues development of its investigational therapy AMX0035 (sodium phenylbutyrate and taurursodiol) in...[ Price : $8.95]
FDA issues an alert after becoming aware that Abiomed sent a letter to customers recommending that certain automated Impella contr...[ Price : $8.95]
BioXcel Therapeutics plans an early 2026 supplemental NDA submission to expand the label of its agitation treatment Igalmi (BXCL50...[ Price : $8.95]
FDA warns Scottsdale, AZ-based Innate Healthcare Institute that it is illegally marketing adulterated and misbranded stem cell pro...[ Price : $8.95]
FDA warns Uscom Kft about Quality System violations in its illegal manufacturing and marketing of adulterated spirometers at its f...[ Price : $8.95]
FDA approves supplemental BLAs from Moderna and Pfizer/BioNTech for their mRNA Covid-19 vaccines that target the LP.8.1 variant of...[ Price : $8.95]
Regeneron Pharmaceuticals releases favorable Phase 3 data for its RNA-based therapy cemdisiran and says it will seek FDA approval ...[ Price : $8.95]
Eli Lilly plans to seek approval for its investigational obesity pill orforglipron following positive topline results from the Pha...